DOI: 10.17140/drmtoj-8-153 ISSN: 2473-4799

Effective Management of Refractory Folliculitis Decalvans Using Secukinumab

Adel Al-Santali, Wasan Al-Qurashi

This case study reports the successful management of a refractory case of folliculitis decalvans in a 40-year-old female patientusing Secukinumab, an interleukin-17A (IL-17A) inhibitor. The patient had a 14-year history of the condition, which had provenresistant to previous treatments, including topical Betamethasone scalp lotion, Ketoconazole shampoo, and Adalimumab. Thiscase highlights the potential efficacy of Secukinumab as a therapeutic option for folliculitis decalvans refractory to conventionaltreatments.

More from our Archive